H Arai, M Tanaka, K Ohta, T Kojo, K Niijima, M Imawari. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultChronic DiseaseFemaleHepatitis C/therapyHumansInterferon alpha-2Interferon-alpha/administration & dosageInterferon-alpha/adverse effectsInterferon-alpha/therapeutic useMuscular Diseases/etiologyMuscular Diseases/physiopathologyNeck MusclesPain/etiologyRecombinant Proteins
Substances: See more » Interferon alpha-2Interferon-alphaRecombinant Proteins
Year: 1995 PMID: 7677847 DOI: 10.1016/s0140-6736(95)90490-5
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321